Kawakami et al., 2000 - Google Patents
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK …Kawakami et al., 2000
View PDF- Document ID
- 18219233862424811132
- Author
- Kawakami K
- Koguchi Y
- Qureshi M
- Miyazato A
- Yara S
- Kinjo Y
- Iwakura Y
- Takeda K
- Akira S
- Kurimoto M
- Saito A
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
The aim of this study was to examine the contribution of IL-18 in host defense against infection caused by Cryptococcus neoformans in mice with defective IL-12 production. Experiments were conducted in mice with a targeted disruption of the gene for IL-12p40 …
- 102100016020 IFNG 0 title abstract description 93
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kawakami et al. | IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK cells | |
| Kinjo et al. | Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40 | |
| Zhou et al. | Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ | |
| Kawakami et al. | IL‐12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans | |
| Uezu et al. | Accumulation of γδ T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans | |
| Zhan et al. | Control of IL-12 and IFN-γ production in response to live or dead bacteria by TNF and other factors | |
| Tateda et al. | Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia | |
| Kawakami et al. | Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12 | |
| Romani et al. | An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. | |
| Bermudez et al. | Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice | |
| Hirst et al. | The role of pneumolysin in pneumococcal pneumonia and meningitis | |
| Doherty et al. | Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. | |
| Desvignes et al. | Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis | |
| Chen et al. | The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans | |
| Kleinschek et al. | IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12 | |
| Hoag et al. | IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant CB-17 mice | |
| Schulz et al. | Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17 | |
| Gonçalves et al. | Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis | |
| Doherty et al. | IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice | |
| Tateda et al. | Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis | |
| Joosten et al. | An IFN-γ-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis | |
| Lin et al. | IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection | |
| Perkins et al. | Salmonella typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively | |
| Zhan et al. | Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro | |
| Kawakami et al. | Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice |